Rating History for Kalvista Pharmaceuticals Inc (KALV) by H.C. Wainwright

More Stocks Rated by H.C. Wainwright | Latest Ratings for KALV
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/1/2026 Andrew Fein Downgrade Neutral
(Buy)		 N/A
(N/A)		 26.66
(27.00)		 1.28% Details